The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 02, 2026
Filed:
Jul. 15, 2022
Applicant:
The Johns Hopkins University, Baltimore, MD (US);
Inventors:
Jordan Green, Nottingham, MD (US);
Jayoung Kim, Baltimore, MD (US);
Stephany Tzeng, Somerville, MA (US);
Assignee:
The Johns Hopkins University, Baltimore, MD (US);
Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C08G 75/12 (2016.01); A61K 9/107 (2006.01); A61K 47/59 (2017.01); A61K 47/60 (2017.01); A61K 47/69 (2017.01); A61K 48/00 (2006.01); A61P 31/00 (2006.01); A61P 35/00 (2006.01); C08G 63/672 (2006.01); C08G 63/685 (2006.01); C08G 63/688 (2006.01); C08G 63/91 (2006.01); C08G 73/02 (2006.01); C08G 81/00 (2006.01); C08L 71/02 (2006.01); C12N 7/00 (2006.01); C12N 15/113 (2010.01); C12N 15/88 (2006.01);
U.S. Cl.
CPC ...
C08G 73/0253 (2013.01); A61K 9/1075 (2013.01); A61K 47/59 (2017.08); A61K 47/60 (2017.08); A61K 47/6907 (2017.08); A61K 47/6935 (2017.08); A61K 48/0041 (2013.01); A61P 31/00 (2018.01); A61P 35/00 (2018.01); C08G 63/672 (2013.01); C08G 63/6856 (2013.01); C08G 63/6886 (2013.01); C08G 63/916 (2013.01); C08G 73/024 (2013.01); C08G 75/12 (2013.01); C08G 81/00 (2013.01); C08L 71/02 (2013.01); C12N 7/00 (2013.01); C12N 15/113 (2013.01); C12N 15/88 (2013.01); C08G 2261/126 (2013.01); C08L 2205/05 (2013.01); C12N 2310/14 (2013.01); C12N 2310/351 (2013.01); C12N 2320/32 (2013.01); C12N 2710/16643 (2013.01);
Abstract
Polyethylene glycol (PEG)-b-poly(β-amino ester) (PBAE) co-polymers (PEG-PBAE) and blends of PEG-PBAEs and PBAEs and their use for delivering drugs, genes, and other pharmaceutical or therapeutic agents safely and effectively to different sites in the body and to different cells, such as cancer cells, are disclosed.